Association of lupus anticoagulant with transient antibodies to prothrombin in a patient with hypoprothrombinemia

Thrombosis Research

Volumn 86, Issue 1, 1997, Pages 73-78

  Amiral, Jean ^a   Aronis, Sophie ^b   Adamtziki, Eftichya ^b   Garoufi, Anastasia ^c   Karpathios, Themistoclis ^c  

^a Immunol Dept PAE P   (France)

^b Haemophilia Haemostasis Unit   (Greece)

^c P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

Auto antibodies; Deficiencies; Intrinsic pathway; Lupus anticoagulant; Prothrombin

Indexed keywords

LUPUS ANTICOAGULANT; PROTHROMBIN;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPOPROTHROMBINEMIA; IMMUNOELECTROPHORESIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SPECIES DIFFERENCE; TARGET CELL; THROMBOSIS;

ADENOVIRIDAE INFECTIONS; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; BLOOD COAGULATION FACTORS; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPOPROTHROMBINEMIAS; LUPUS COAGULATION INHIBITOR; PROTHROMBIN; TIME FACTORS;

EID: 0030965892     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00047-9     Document Type: Article

References (20)

1. TRIPLETT D.A. Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res. 78:1995;1-31.
2. OOSTING J.D., DERKSEN R., BOBBINK I.W.G., HACKENG T.M. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism. Blood. 81:1993;2618-2625.
3. BEVERS E.M., GALLI M., BARBUI T., COMFURIUS P., ZWAAL R.F.A. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostasis. 66:1991;629-632.
4. EDSON J.R., VOGT J.M., HASEGAWA D.K. Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors. Blood. 64:1984;807-816.
5. OOSTING J.D., DERKSEN R., ENTJES H.T.I., BOUMA B.N., DE GROOT P.G. Lupus anticoagulant activity is frequently dependent on the presence of β2-Glycoprotein I. Thromb Haemostasis. 67:1992;499-502.
6. GALLI M., COMFURIUS P., BARBUI T., ZWAAL R.F.A., BEVERS E.M. Anticoagulant activity of β2-Glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemostasis. 68:1992;297-300.
7. EXNER T., SAHMAN N., TRUDINGER B. Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column. Biochem Biophys Res Commun. 155:1988;1001-1007.
8. MCNEIL H.P., SIMPSON R.J., CHESTERMAN C.N., KRILIS S.A. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation : β2-Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA. 87:1990;4120-4124.
9. AMIRAL J., LARRIVAZ I., CLUZEAU D., ADAM M. Standardization of immunoassays for antiphospholipid antibodies with β2GPI and role of other phospholipid cofactors. Haemostasis. 24:1994;191-203.
10. LOELIGER A. Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus. Thromb Diath Haemorrh. 3:1959;237-256.
11. BAJAJ S.P., RAPAPORT S.I., FIERER D.S., HERBST K.D., SCHWARTZ D.B. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood. 61:1983;684-692.
12. FLECK R.A., RAPAPORT S.I., RAO L.V.M. Anti-prothrombin antibodies and the lupus anticoagulant. Blood. 72:1988;512-519.
13. BAUDO F., REDAELLI R., PEZZETTI L., CAIMI T.M., BUSNACH G., PERRINO L., DECATALDO F., TARALLO G. Prothrombin-antibody coexistent with lupus anticoagulant (LA) : clinical study and immunochemical characterization. Thromb Res. 57:1990;279-287.
14. BERNINI J.C., BUCHANAN G.R., ASHCRAFT J. Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr. 123:1993;937-939.
15. PEACOCK N.W., LEVINE S.P. Case report: The lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med Sci. 307:1994;346-349.
16. PERMPIKUL P., RAO L.V.M., RAPAPORT S.A. Functional and binding studies of the roles of prothrombin and β2-Glycoprotein I in the expression of lupus anticoagulant activity. Blood. 83:1994;2878-2892.
17. LEE M.T., NARDI M.A., HU G., HADZI-NESIC J., KARPATKIN M. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1. 1 2 -year-old girl: report of a case and review of the literature Am J Hematol. 51:1996;307-314.
18. BERRUYER M., AMIRAL J., FRENCH P., BELLEVILLE J., BASTIEN O., CLERC J., KASSIR A., ESTANOV S., DECHAVANNE M. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. J Thorac Cardiovasc Surg. 105:1993;892-897.
19. SCHOUSBOE I., RASMUSSEN M.S. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by β2-Glycoprotein I and anti-β2-Glycoprotein I. Thromb Haemostasis. 73:1995;798-804.
20. WU J.R., LENTZ B.R. Phospholipid-specific conformational changes in human prothrombin upon binding to procoagulant acidic lipid membranes. Thromb Haemostasis. 71:1994;596-604.